-
-
-
-
-
-
-
Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System
-
-
-
-
-
-
-
Daxor's Blood Volume Analysis Uncovers Hidden Heart Failure Subtype in Nearly 1 in 5 Patients, Enabling Targeted Treatment
-
-
-
-
-
-
-
Daxor Corp. (DXR) Appoints John L. Jefferies, M.D. as Chief Medical Officer
-
-
-
-
-
-
-
Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test for Heart Failure Patients at Key Scientific Society Meeting
69,742 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

